Review



bellocell continuous cell culture system  (Cesco Bioengineering Co)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    Cesco Bioengineering Co bellocell continuous cell culture system
    Bellocell Continuous Cell Culture System, supplied by Cesco Bioengineering Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bellocell continuous cell culture system/product/Cesco Bioengineering Co
    Average 90 stars, based on 1 article reviews
    bellocell continuous cell culture system - by Bioz Stars, 2026-05
    90/100 stars

    Images



    Similar Products

    bellocell continuous cell culture system  (Cesco Bioengineering Co)
    90
    Cesco Bioengineering Co bellocell continuous cell culture system
    Bellocell Continuous Cell Culture System, supplied by Cesco Bioengineering Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bellocell continuous cell culture system/product/Cesco Bioengineering Co
    Average 90 stars, based on 1 article reviews
    bellocell continuous cell culture system - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    oscillating bioreactor bellocell system bellocell hd continuous cell culture system  (Cesco Bioengineering Co)
    90
    Cesco Bioengineering Co oscillating bioreactor bellocell system bellocell hd continuous cell culture system
    Oscillating Bioreactor Bellocell System Bellocell Hd Continuous Cell Culture System, supplied by Cesco Bioengineering Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/oscillating bioreactor bellocell system bellocell hd continuous cell culture system/product/Cesco Bioengineering Co
    Average 90 stars, based on 1 article reviews
    oscillating bioreactor bellocell system bellocell hd continuous cell culture system - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    the bellocell continuous cell culture system  (Cesco Bioengineering Co)
    90
    Cesco Bioengineering Co the bellocell continuous cell culture system
    The Bellocell Continuous Cell Culture System, supplied by Cesco Bioengineering Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/the bellocell continuous cell culture system/product/Cesco Bioengineering Co
    Average 90 stars, based on 1 article reviews
    the bellocell continuous cell culture system - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier
    bellocell hd continuous cell culture system  (Cesco Bioengineering Co)
    90
    Cesco Bioengineering Co bellocell hd continuous cell culture system
    2209-23 cell growth and HCV replicon levels in the <t>BelloCell</t> system. (A) Cell growth was measured daily. 2209-23 cells were removed from carrier flakes with trypsin-EDTA, and viable cells were enumerated using the trypan blue exclusion method. Data points represent the average cell count from three independent samples, and error bars correspond to 1 standard deviation. (B) Replicon stability was assessed by quantifying the luciferase activity of 2209-23 cells from 6 carrier flakes harvested each day from the BelloCell bottle.
    Bellocell Hd Continuous Cell Culture System, supplied by Cesco Bioengineering Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/bellocell hd continuous cell culture system/product/Cesco Bioengineering Co
    Average 90 stars, based on 1 article reviews
    bellocell hd continuous cell culture system - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    2209-23 cell growth and HCV replicon levels in the BelloCell system. (A) Cell growth was measured daily. 2209-23 cells were removed from carrier flakes with trypsin-EDTA, and viable cells were enumerated using the trypan blue exclusion method. Data points represent the average cell count from three independent samples, and error bars correspond to 1 standard deviation. (B) Replicon stability was assessed by quantifying the luciferase activity of 2209-23 cells from 6 carrier flakes harvested each day from the BelloCell bottle.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System

    doi: 10.1128/AAC.05383-11

    Figure Lengend Snippet: 2209-23 cell growth and HCV replicon levels in the BelloCell system. (A) Cell growth was measured daily. 2209-23 cells were removed from carrier flakes with trypsin-EDTA, and viable cells were enumerated using the trypan blue exclusion method. Data points represent the average cell count from three independent samples, and error bars correspond to 1 standard deviation. (B) Replicon stability was assessed by quantifying the luciferase activity of 2209-23 cells from 6 carrier flakes harvested each day from the BelloCell bottle.

    Article Snippet: A detailed description of the BelloCell system (BelloCell HD continuous cell culture system; catalog no. BS7000; Cesco Bioengineering Inc., Taichung, Taiwan) is described elsewhere ( 8 , 22 ).

    Techniques: Cell Counting, Standard Deviation, Luciferase, Activity Assay

    Total number of clones analyzed from each BelloCell treatment arm

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System

    doi: 10.1128/AAC.05383-11

    Figure Lengend Snippet: Total number of clones analyzed from each BelloCell treatment arm

    Article Snippet: A detailed description of the BelloCell system (BelloCell HD continuous cell culture system; catalog no. BS7000; Cesco Bioengineering Inc., Taichung, Taiwan) is described elsewhere ( 8 , 22 ).

    Techniques: Clone Assay

    Dose-dependent inhibition of the HCV replicon by MK-4519 in BelloCell dose-ranging studies. Luciferase activity (A) and HCV RNA relative to GAPDH RNA (B) of 2209-23 cells at various times after MK-4519 exposure. BelloCell bottles were inoculated with 6 × 107 replicon-bearing 2209-23 cells and continuously infused with 0, 6, 10, or 30 nM MK-4519. Data points indicate median values of three independent samples, and error bars correspond to 1 standard deviation.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System

    doi: 10.1128/AAC.05383-11

    Figure Lengend Snippet: Dose-dependent inhibition of the HCV replicon by MK-4519 in BelloCell dose-ranging studies. Luciferase activity (A) and HCV RNA relative to GAPDH RNA (B) of 2209-23 cells at various times after MK-4519 exposure. BelloCell bottles were inoculated with 6 × 107 replicon-bearing 2209-23 cells and continuously infused with 0, 6, 10, or 30 nM MK-4519. Data points indicate median values of three independent samples, and error bars correspond to 1 standard deviation.

    Article Snippet: A detailed description of the BelloCell system (BelloCell HD continuous cell culture system; catalog no. BS7000; Cesco Bioengineering Inc., Taichung, Taiwan) is described elsewhere ( 8 , 22 ).

    Techniques: Inhibition, Luciferase, Activity Assay, Standard Deviation

    MK-4519 concentrations, determined by LC/MS/MS, in the BelloCell system for the dose-ranging study. Triangles, MK-4519 concentrations observed; lines, targeted concentration-time profile.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System

    doi: 10.1128/AAC.05383-11

    Figure Lengend Snippet: MK-4519 concentrations, determined by LC/MS/MS, in the BelloCell system for the dose-ranging study. Triangles, MK-4519 concentrations observed; lines, targeted concentration-time profile.

    Article Snippet: A detailed description of the BelloCell system (BelloCell HD continuous cell culture system; catalog no. BS7000; Cesco Bioengineering Inc., Taichung, Taiwan) is described elsewhere ( 8 , 22 ).

    Techniques: Liquid Chromatography with Mass Spectroscopy, Concentration Assay

    Selection of drug-resistant NS3/4A replicon variants as a result of MK-4519 pressure in BelloCell dose-ranging studies. Cellular RNA was extracted from 2209-23 cells that were treated with various concentrations of MK-4519 in the dose-range study. Replicon RNA was assessed for mutations by clonal sequencing as described in Materials and Methods. Pie charts show the genotype and frequency of replicon populations harvested from the 6 nM (A and D), 10 nM (B and E), and 30 nM (C and F) treatment arms at day 6 (top) and day 13 (bottom) after drug exposure.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System

    doi: 10.1128/AAC.05383-11

    Figure Lengend Snippet: Selection of drug-resistant NS3/4A replicon variants as a result of MK-4519 pressure in BelloCell dose-ranging studies. Cellular RNA was extracted from 2209-23 cells that were treated with various concentrations of MK-4519 in the dose-range study. Replicon RNA was assessed for mutations by clonal sequencing as described in Materials and Methods. Pie charts show the genotype and frequency of replicon populations harvested from the 6 nM (A and D), 10 nM (B and E), and 30 nM (C and F) treatment arms at day 6 (top) and day 13 (bottom) after drug exposure.

    Article Snippet: A detailed description of the BelloCell system (BelloCell HD continuous cell culture system; catalog no. BS7000; Cesco Bioengineering Inc., Taichung, Taiwan) is described elsewhere ( 8 , 22 ).

    Techniques: Selection, Sequencing

    Inhibition of the HCV replicon by MK-4519 at different dosing intervals in BelloCell dose-fractionation studies. Luciferase activity (A) and relative HCV RNA (B) quantified from 2209-23 cells harvested from the BelloCell system at various times after MK-4519 exposure. BelloCell bottles were inoculated with 6 × 107 2209-23 cells. The 24-h AUC exposure for 10 nM MK-4519 (240 nM · h) was administered q24h, q12h, or as a continuous infusion. Data points indicate median values of three independent samples, and error bars correspond to 1 standard deviation.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System

    doi: 10.1128/AAC.05383-11

    Figure Lengend Snippet: Inhibition of the HCV replicon by MK-4519 at different dosing intervals in BelloCell dose-fractionation studies. Luciferase activity (A) and relative HCV RNA (B) quantified from 2209-23 cells harvested from the BelloCell system at various times after MK-4519 exposure. BelloCell bottles were inoculated with 6 × 107 2209-23 cells. The 24-h AUC exposure for 10 nM MK-4519 (240 nM · h) was administered q24h, q12h, or as a continuous infusion. Data points indicate median values of three independent samples, and error bars correspond to 1 standard deviation.

    Article Snippet: A detailed description of the BelloCell system (BelloCell HD continuous cell culture system; catalog no. BS7000; Cesco Bioengineering Inc., Taichung, Taiwan) is described elsewhere ( 8 , 22 ).

    Techniques: Inhibition, Fractionation, Luciferase, Activity Assay, Standard Deviation

    Pharmacokinetic analysis of MK-4519 in the BelloCell system. PK samples were harvested from BelloCell units, and MK-4519 concentrations were determined by LC/MS/MS. Triangles, measured concentrations; lines, target concentration-time profiles.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System

    doi: 10.1128/AAC.05383-11

    Figure Lengend Snippet: Pharmacokinetic analysis of MK-4519 in the BelloCell system. PK samples were harvested from BelloCell units, and MK-4519 concentrations were determined by LC/MS/MS. Triangles, measured concentrations; lines, target concentration-time profiles.

    Article Snippet: A detailed description of the BelloCell system (BelloCell HD continuous cell culture system; catalog no. BS7000; Cesco Bioengineering Inc., Taichung, Taiwan) is described elsewhere ( 8 , 22 ).

    Techniques: Liquid Chromatography with Mass Spectroscopy, Concentration Assay

    Detection of NS3/4A mutations associated with MK-4519 resistance in replicons harvested from dose-fractionation studies. A 24-h AUC exposure of 240 nM · h of MK-4519 was delivered into the BelloCell system at dosing intervals of q24h or q12h or as a continuous infusion. Cellular RNA was extracted from 2209-23 cells from each treatment arm, and NS3/4a replicon mutants were quantified by clonal sequencing. The pie charts show the replicon populations for the continuous-infusion (A and D), q24h (B and E), and q12h (C and F) dosing intervals at day 6 (top) and day 13 (bottom) after drug exposure.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System

    doi: 10.1128/AAC.05383-11

    Figure Lengend Snippet: Detection of NS3/4A mutations associated with MK-4519 resistance in replicons harvested from dose-fractionation studies. A 24-h AUC exposure of 240 nM · h of MK-4519 was delivered into the BelloCell system at dosing intervals of q24h or q12h or as a continuous infusion. Cellular RNA was extracted from 2209-23 cells from each treatment arm, and NS3/4a replicon mutants were quantified by clonal sequencing. The pie charts show the replicon populations for the continuous-infusion (A and D), q24h (B and E), and q12h (C and F) dosing intervals at day 6 (top) and day 13 (bottom) after drug exposure.

    Article Snippet: A detailed description of the BelloCell system (BelloCell HD continuous cell culture system; catalog no. BS7000; Cesco Bioengineering Inc., Taichung, Taiwan) is described elsewhere ( 8 , 22 ).

    Techniques: Fractionation, Sequencing

    Fitted pharmacokinetics for MK-4519 against a genotype 1b HCV replicon in the BelloCell system. (A) MK-4519 was delivered into BelloCell units as a continuous infusion of 6, 10, or 30 nM. (B) A 24-h AUC exposure of 240 nM · h of MK-4519 was administered q24h or q12h and eliminated from the system with a half-life of 3.6 h. Lines, model-simulated concentration-time profiles (fitted); symbols, MK-4519 concentrations measured in the system.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System

    doi: 10.1128/AAC.05383-11

    Figure Lengend Snippet: Fitted pharmacokinetics for MK-4519 against a genotype 1b HCV replicon in the BelloCell system. (A) MK-4519 was delivered into BelloCell units as a continuous infusion of 6, 10, or 30 nM. (B) A 24-h AUC exposure of 240 nM · h of MK-4519 was administered q24h or q12h and eliminated from the system with a half-life of 3.6 h. Lines, model-simulated concentration-time profiles (fitted); symbols, MK-4519 concentrations measured in the system.

    Article Snippet: A detailed description of the BelloCell system (BelloCell HD continuous cell culture system; catalog no. BS7000; Cesco Bioengineering Inc., Taichung, Taiwan) is described elsewhere ( 8 , 22 ).

    Techniques: Drug discovery, Concentration Assay

    Fitted luciferase activities for MK-4519 against a genotype 1b HCV replicon in BelloCell dose-range and dose-fractionation studies. (A to D) Graphs based on the dose-range study where various concentrations of MK-4519 were administered into BelloCell bottles as a continuous infusion. (A, B, D, and F) Graphs based on the dose-fractionation study in which a 24-h AUC exposure of 240 nM · h was fractionated at q24h, q12h, and continuous-infusion dosing intervals. A half-life of 3.6 h was simulated for MK-4519 in the dose-fractionation study. Lines, luciferase activity simulated by the mathematical model; symbols, luciferase activity observed in the BelloCell system at the specified time point; blue lines and symbols, luciferase activity from the total replicon population; red lines and symbols, luciferase activity from the mutant replicon subpopulation.

    Journal: Antimicrobial Agents and Chemotherapy

    Article Title: Pharmacodynamic Analysis of a Serine Protease Inhibitor, MK-4519, against Hepatitis C Virus Using a Novel In Vitro Pharmacodynamic System

    doi: 10.1128/AAC.05383-11

    Figure Lengend Snippet: Fitted luciferase activities for MK-4519 against a genotype 1b HCV replicon in BelloCell dose-range and dose-fractionation studies. (A to D) Graphs based on the dose-range study where various concentrations of MK-4519 were administered into BelloCell bottles as a continuous infusion. (A, B, D, and F) Graphs based on the dose-fractionation study in which a 24-h AUC exposure of 240 nM · h was fractionated at q24h, q12h, and continuous-infusion dosing intervals. A half-life of 3.6 h was simulated for MK-4519 in the dose-fractionation study. Lines, luciferase activity simulated by the mathematical model; symbols, luciferase activity observed in the BelloCell system at the specified time point; blue lines and symbols, luciferase activity from the total replicon population; red lines and symbols, luciferase activity from the mutant replicon subpopulation.

    Article Snippet: A detailed description of the BelloCell system (BelloCell HD continuous cell culture system; catalog no. BS7000; Cesco Bioengineering Inc., Taichung, Taiwan) is described elsewhere ( 8 , 22 ).

    Techniques: Luciferase, Fractionation, Activity Assay, Mutagenesis